Laura Corradini PhD

Dr. Laura Corradini received her degree in medicinal chemistry and technology, and qualified as Pharmacist at the University of Milan (Italy). Subsequently, she obtained her PhD in biotechnology at the same University. Dr. Corradini worked for more than ten years in preclinical research at Schering-Plough Research and Development (R&D) and Pfizer R&D in the field of neuroscience and chronic pain, respectively. Since joining Boehringer Ingelheim (BI) in 2009, she has held several positions in R&D as CNS Pharmacologist for pain and ophthalmology. Dr. Corradini currently acts as Deputy Global Head of Business Development & Licensing CNS at BI. She is responsible for search and evaluation of partnering opportunities in the therapeutic area CNS with focus to innovative programs addressing unmet medical needs in neuropsychiatry. Dr Corradini is chair of a BI’s cross-functional CNS Licensing Advisory Team. The strategic partnering focus of Dr. Corradini and her team is novel therapeutic approaches to treating neuropsychiatric disorders.